What Immune Support Is Needed for CHH?
At a Glance
Children with cartilage-hair hypoplasia (CHH) often require customized immune support due to partial T-cell deficiency. Treatment may include preventative antibiotics like Bactrim to stop infections, immunoglobulin replacement therapy (IRT), and careful lifelong monitoring by an immunologist.
In this answer
3 sections
Many parents of children with cartilage-hair hypoplasia (CHH) wonder what daily life will look like regarding immune support medication. For children with partial T-cell deficiency who do not receive a stem cell transplant, doctors will often prescribe daily preventative medications, such as antibiotics or antifungal agents, to protect against severe infections. However, because CHH affects the immune system differently in each person [1][2], not every child will need the exact same daily routine.
Preventative Antibiotics and Antifungals
The immune system in children with CHH can range from having very mild issues to more severe cellular immunodeficiency [3][2]. When a child has a meaningful partial T-cell deficiency but is not undergoing a stem cell transplant, their care team may initiate antimicrobial prophylaxis (preventative medications) to stop opportunistic infections before they start.
- Antibiotics: One of the most common preventative medications prescribed is TMP-SMX (Bactrim). This daily or thrice-weekly antibiotic is specifically used to prevent Pneumocystis jirovecii pneumonia (PJP), a severe lung infection that can be dangerous for individuals with weakened T-cells. While there is no single, universal rule for when to start Bactrim in CHH [2][4], immunology teams will look at your child’s specific history of recurrent infections and laboratory tests to decide when it is necessary [5][6]. Be aware that long-term use of Bactrim can cause side effects like mild stomach upset or increased sensitivity to the sun.
- Antifungal Agents: In some cases, children may also be prescribed daily antifungal medications to prevent difficult-to-treat fungal infections. The decision to use these medications is highly individualized and relies heavily on the child’s specific immune phenotype (their unique pattern of immune strengths and weaknesses) and history of sickness [4][7].
Additional Immune Support
Beyond daily pills or liquid medications, some children with CHH need extra support to help their bodies recognize and fight off germs.
- Immunoglobulin Replacement Therapy (IRT): If your child has low levels of protective antibodies (such as low IgG) or fails to mount a response to vaccines, alongside a history of recurrent pneumonia or sepsis, they may be given IRT [6][5]. This treatment provides the body with the antibodies it cannot make on its own and is given through regular infusions into a vein or under the skin [2][3].
- Vaccinations: Vaccines are a crucial form of immune support, but they require careful consideration in CHH. Because live-attenuated vaccines contain a weakened form of the virus, they can actually cause the disease they are meant to prevent in someone with a severe T-cell deficiency. While standard guidelines are still being developed, some children with only mild immunodeficiency may be able to safely receive live vaccines, such as the chickenpox (varicella-zoster virus) vaccine [8]. However, this must always be decided by your child’s immunology team. You should also consult your doctor before siblings or close household contacts receive live vaccines, as viral shedding can pose a risk.
The Importance of Ongoing Monitoring
Even if your child is currently asymptomatic and not taking daily medications, they still require regular, lifelong monitoring by a multidisciplinary medical team [2][1]. This typically means clinic visits every 6 to 12 months, or as directed by your doctor. The immune system in CHH can change over time, and doctors will use specific laboratory tests, such as lymphocyte subsets (to count specific types of immune cells) or functional immune assays, to measure how well the immune system is working [4]. If immune function declines, the care team can quickly start preventative medications to keep your child safe.
Common questions in this guide
Why do some children with CHH need preventative antibiotics?
Are live vaccines safe for a child with cartilage-hair hypoplasia?
What is Immunoglobulin Replacement Therapy (IRT)?
How often should a child's immune system be checked for CHH?
Questions for Your Doctor
4 questions
- •Based on my child's recent lymphocyte subsets, do they meet the criteria for starting or stopping preventative antibiotics like Bactrim?
- •What specific signs of infection should prompt an immediate call to the clinic or a trip to the emergency room while my child is on preventative medications?
- •Is it safe for my child's siblings to receive live-attenuated vaccines, such as the rotavirus or MMR vaccine?
- •Does my child's current antibody testing indicate a need to discuss Immunoglobulin Replacement Therapy (IRT)?
Questions for You
3 questions
- •Have I noticed any side effects from my child's daily medications, such as stomach upset or skin rashes, that I should discuss with the care team?
- •Am I keeping an organized record of my child's past infections, including how long they lasted and which antibiotics were used to treat them?
- •How comfortable am I administering daily medications or managing potential at-home treatments like subcutaneous IRT?
References
References (8)
- 1
A 30-Year Prospective Follow-Up Study Reveals Risk Factors for Early Death in Cartilage-Hair Hypoplasia.
Vakkilainen S, Taskinen M, Klemetti P, et al.
Frontiers in immunology 2019; (10()):1581 doi:10.3389/fimmu.2019.01581.
PMID: 31379817 - 2
Immunodeficiency in cartilage-hair hypoplasia: Pathogenesis, clinical course and management.
Vakkilainen S, Taskinen M, Mäkitie O
Scandinavian journal of immunology 2020; (92(4)):e12913 doi:10.1111/sji.12913.
PMID: 32506568 - 3
[Cartilage-hair hypoplasia. A case report].
Staines-Boones TA, González-Villarreal MG, Hernández-Fernández C
Revista alergia Mexico (Tecamachalco, Puebla, Mexico : 1993) 2019; (66(3)):379-383 doi:10.29262/ram.v66i3.561.
PMID: 31606024 - 4
Abnormal Newborn Screening Follow-up for Severe Combined Immunodeficiency in an Amish Cohort with Cartilage-Hair Hypoplasia.
Scott EM, Chandra S, Li J, et al.
Journal of clinical immunology 2020; (40(2)):321-328 doi:10.1007/s10875-019-00739-9.
PMID: 31903518 - 5
Shorter birth length and decreased T-cell production and function predict severe infections in children with non-severe combined immunodeficiency cartilage-hair hypoplasia.
Pello E, Kainulainen L, Vakkilainen M, et al.
The journal of allergy and clinical immunology. Global 2024; (3(1)):100190 doi:10.1016/j.jacig.2023.100190.
PMID: 38187867 - 6
A Wide Spectrum of Autoimmune Manifestations and Other Symptoms Suggesting Immune Dysregulation in Patients With Cartilage-Hair Hypoplasia.
Vakkilainen S, Mäkitie R, Klemetti P, et al.
Frontiers in immunology 2018; (9()):2468 doi:10.3389/fimmu.2018.02468.
PMID: 30410491 - 7
Cartilage-hair hypoplasia associated with isolated hypoganglionosis: A case report.
Yasui Y, Kohno M, Nishida S, et al.
Congenital anomalies 2017; (57(1)):32-34 doi:10.1111/cga.12175.
PMID: 27270827 - 8
The Safety and Efficacy of Live Viral Vaccines in Patients With Cartilage-Hair Hypoplasia.
Vakkilainen S, Kleino I, Honkanen J, et al.
Frontiers in immunology 2020; (11()):2020 doi:10.3389/fimmu.2020.02020.
PMID: 32849667
This page is for informational purposes only and does not replace professional medical advice. Always consult your child's immunology team regarding their specific immune support needs, vaccination safety, and medication regimen.
Get notified when new evidence is published on Cartilage-hair hypoplasia.
We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.